Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet « metajournal.com

Am J Cardiovasc Drugs · Aug 2019

Letter

Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?

no abstract available

read more…
- Vittoria Cammisotto, Giuseppe Biondi-Zoccai, Giacomo Frati, and Arturo Giordano.
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- Am J Cardiovasc Drugs. 2019 Aug 1; 19 (4): 377-379.
no abstract available

Pubmed Full text Copy Citation

Add institutional full text...

Notes
Related articles
- Randomized Controlled Trial
  
  Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
  
  N. Engl. J. Med. 2019 Oct 17; 381 (16): 1524-1534.
- Review
  
  Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials.
  
  BMC Pharmacol Toxicol. 2017 Dec 12; 18 (1): 80.
- Meta Analysis
  
  Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis.
  
  Bmc Cardiovasc Disor. 2020 Oct 1; 20 (1): 430.
hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,704,841 articles already indexed!